Although further studies are required to validate and fully elucidate the molecular mechanism, our observations point towards two major clinical implications: (1) SGC could be related to co-occurrence of pathogenic TP53 and RAD51C variants, and cause a phenotype reminiscent of MTS independent of MMR deficiency. The gene discussed is RAD51C; the disease is mismatch repair cancer syndrome 1.